Skip to search.
 All Ordinaries Down 0.36%

Athersys, Inc. (ATHX)

-NasdaqCM
1.50 18 Jan 08:00
|Pre-Market : 1.52 Up 0.02 (1.33%) 01:06 - Nasdaq Real-Time Price
Prev Close:1.50
Open:N/A
Bid:1.53 x 100
Ask:1.59 x 100
1y Target Est:7.67
Beta:-0.94354
Earnings Date:8 Mar - 13 Mar (Est.)
Day's Range:N/A - N/A
52wk Range:1.03 - 2.90
Volume:499
Avg Vol (3m):398,769
Market Cap:128.25M
P/E (ttm):N/A
EPS (ttm):-0.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ATHX 0.00%128.25M
1N/A
OSIR165.72M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.18
Quarterly EPS Est (Dec-16) :-0.08
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):-0.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback